Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

2型糖尿病 医学 利拉鲁肽 非酒精性脂肪肝 胰高血糖素样肽1受体 脂肪性肝炎 肥胖 糖尿病 脂肪肝 胰高血糖素样肽-1 内科学 生物信息学 药理学 内分泌学 受体 疾病 兴奋剂 生物
作者
Ronald Goldenberg,Jeremy Gilbert,Priya Manjoo,Sue D. Pedersen,Vincent Woo,Julie A. Lovshin
出处
期刊:Obesity Reviews [Wiley]
卷期号:25 (3) 被引量:2
标识
DOI:10.1111/obr.13663
摘要

Summary Type 2 diabetes (T2D), obesity, and nonalcoholic fatty liver disease/nonalacoholic steatohepatitis (NAFLD/NASH) share mutual causalities. Medications that may offer clinical benefits to all three conditions are being developed. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are approved for the management of T2D and obesity and there is great interest in evaluating higher doses of available GLP‐1RAs and developing novel GLP‐1RA‐based co‐agonists to provide greater reductions in glycated hemoglobin (HbA1c) and body weight as well as modifying NAFLD/NASH complications in clinically meaningful ways. High‐dose GLP‐1RAs and multi‐hormonal strategies including GLP‐1R agonism have either already been approved or are in development for managing T2D, obesity, or NASH. We provide a mechanistic outline with a detailed summary of the available clinical data and ongoing trials that are adjudicating the impact of high‐dose GLP‐1RAs, unimolecular, and multimolecular GLP‐1R‐based co‐agonists in populations living with T2D, obesity, or NASH. The available trial findings are aligned with preclinical observations, showing clinical efficacy and safety thus providing optimism for the expansion of GLP‐1R‐based drug classes for managing the triad of T2D, obesity and NASH. Development, access, and wide‐spread utilization of these new therapeutic approaches will offer important opportunities to markedly improve the collective global burden of T2D, obesity, and NASH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YC发布了新的文献求助10
刚刚
鲤鱼一一完成签到,获得积分10
刚刚
科目三应助壮观以松采纳,获得10
1秒前
biocx完成签到,获得积分10
1秒前
ardejiang发布了新的文献求助10
2秒前
小毛完成签到,获得积分10
2秒前
Debjor发布了新的文献求助10
3秒前
Mercury完成签到,获得积分10
4秒前
4秒前
顾矜应助dbzdq采纳,获得10
5秒前
qj发布了新的文献求助10
5秒前
太阳完成签到,获得积分10
6秒前
7秒前
在水一方应助陈秋采纳,获得10
7秒前
千宝完成签到 ,获得积分10
8秒前
Lllllllll完成签到,获得积分10
8秒前
打打应助科研通管家采纳,获得10
9秒前
Akim应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
ccm应助科研通管家采纳,获得10
9秒前
NexusExplorer应助科研通管家采纳,获得10
9秒前
小米粥完成签到,获得积分10
9秒前
9秒前
充电宝应助科研通管家采纳,获得10
10秒前
Akim应助科研通管家采纳,获得10
10秒前
隐形曼青应助科研通管家采纳,获得10
10秒前
汉堡包应助科研通管家采纳,获得10
10秒前
Pinky_tea应助科研通管家采纳,获得50
10秒前
10秒前
10秒前
11秒前
12秒前
Xxi完成签到,获得积分10
12秒前
12秒前
13秒前
curryww发布了新的文献求助20
13秒前
13秒前
火火完成签到,获得积分10
13秒前
彭于晏应助姜姜姜采纳,获得10
15秒前
从容芮应助张张采纳,获得10
15秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
An Introduction to Geographical and Urban Economics: A Spiky World Book by Charles van Marrewijk, Harry Garretsen, and Steven Brakman 600
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3154330
求助须知:如何正确求助?哪些是违规求助? 2805172
关于积分的说明 7863751
捐赠科研通 2463360
什么是DOI,文献DOI怎么找? 1311251
科研通“疑难数据库(出版商)”最低求助积分说明 629543
版权声明 601821